Cargando…
Discovery of Novel Non-Steroidal Cytochrome P450 17A1 Inhibitors as Potential Prostate Cancer Agents
The current study presents the design, synthesis, and evaluation of novel cytochrome P450 17A1 (CYP17A1) ligands. CYP17A1 is a key enzyme in the steroidogenic pathway that produces androgens among other steroids, and it is implicated in prostate cancer. The obtained compounds are potent enzyme inhib...
Autores principales: | Wróbel, Tomasz M., Rogova, Oksana, Andersen, Kasper L., Yadav, Rahul, Brixius-Anderko, Simone, Scott, Emily E., Olsen, Lars, Jørgensen, Flemming Steen, Björkling, Fredrik |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7402352/ https://www.ncbi.nlm.nih.gov/pubmed/32660148 http://dx.doi.org/10.3390/ijms21144868 |
Ejemplares similares
-
Synthesis and Structure–Activity Relationships of Novel Non-Steroidal CYP17A1 Inhibitors as Potential Prostate Cancer Agents
por: Wróbel, Tomasz M., et al.
Publicado: (2022) -
Non-steroidal
CYP17A1 Inhibitors: Discovery and Assessment
por: Wróbel, Tomasz M., et al.
Publicado: (2023) -
Promising Tools in Prostate Cancer Research: Selective Non-Steroidal Cytochrome P450 17A1 Inhibitors
por: Bonomo, Silvia, et al.
Publicado: (2016) -
Nothing wrong with me
por: Brixius-Anderko, Simone
Publicado: (2023) -
Structural analysis of Cytochrome P450 BM3 mutant M11 in complex with dithiothreitol
por: Frydenvang, Karla, et al.
Publicado: (2019)